SYK INHIBITORS IN COMBINATION WITH HYPOMETHYLATING AGENTS

摘要

Provided herein are methods and compositions for treating myeloproliferative diseases and disorders. In some embodiments, the method comprises administering an effective amount of a spleen tyrosine kinase inhibitor and a hypomethylating agent, lenalidomide or antithymocyte globulin to a patient in need thereof.